Zhejiang Hisun Pharmaceutical Co., Ltd.

SHSE:600267 Stock Report

Market Cap: CN¥9.8b

Zhejiang Hisun Pharmaceutical Future Growth

Future criteria checks 3/6

Zhejiang Hisun Pharmaceutical is forecast to grow earnings and revenue by 43.8% and 2.6% per annum respectively. EPS is expected to grow by 44% per annum. Return on equity is forecast to be 5% in 3 years.

Key information

43.8%

Earnings growth rate

44.0%

EPS growth rate

Pharmaceuticals earnings growth18.8%
Revenue growth rate2.6%
Future return on equity5.0%
Analyst coverage

Low

Last updated30 Oct 2024

Recent future growth updates

Recent updates

Zhejiang Hisun Pharmaceutical Co., Ltd.'s (SHSE:600267) Shares Lagging The Industry But So Is The Business

Sep 26
Zhejiang Hisun Pharmaceutical Co., Ltd.'s (SHSE:600267) Shares Lagging The Industry But So Is The Business

These 4 Measures Indicate That Zhejiang Hisun Pharmaceutical (SHSE:600267) Is Using Debt Reasonably Well

Apr 30
These 4 Measures Indicate That Zhejiang Hisun Pharmaceutical (SHSE:600267) Is Using Debt Reasonably Well

Investors Don't See Light At End Of Zhejiang Hisun Pharmaceutical Co., Ltd.'s (SHSE:600267) Tunnel

Mar 29
Investors Don't See Light At End Of Zhejiang Hisun Pharmaceutical Co., Ltd.'s (SHSE:600267) Tunnel

Earnings and Revenue Growth Forecasts

SHSE:600267 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20269,991459N/AN/A1
12/31/20259,753431N/AN/A1
12/31/20249,329426N/AN/A1
9/30/20249,547-201,5301,637N/A
6/30/20249,556-621,4321,542N/A
3/31/202410,036-771,3901,513N/A
12/31/202310,373-931,2631,503N/A
9/30/202311,9946001,5391,909N/A
6/30/202312,3605741,3391,759N/A
3/31/202312,1235861,6072,084N/A
12/31/202212,0374891,5352,066N/A
9/30/202211,7733191,5072,163N/A
6/30/202211,8695261,7922,456N/A
3/31/202212,0464961,1311,793N/A
12/31/202112,1364871,1141,737N/A
9/30/202112,3085748891,363N/A
6/30/202112,0404576591,184N/A
3/31/202111,9236146631,296N/A
12/31/202011,3544178981,590N/A
9/30/202010,914-8196871,362N/A
6/30/202010,7242811041,019N/A
3/31/202010,774-102341,124N/A
12/31/201911,07293-378698N/A
9/30/201910,694755-6911,098N/A
6/30/201910,522-455-3351,424N/A
3/31/201910,163-472-6121,259N/A
12/31/201810,187-492-3031,446N/A
9/30/201810,200163901,672N/A
6/30/201810,39815N/A1,608N/A
3/31/201810,65518N/A1,554N/A
12/31/201710,57214N/A1,353N/A
9/30/201710,574-120N/A963N/A
6/30/201710,509-101N/A835N/A
3/31/201710,090-94N/A840N/A
12/31/20169,733-94N/A776N/A
9/30/20169,39640N/A594N/A
6/30/20168,986-3N/A413N/A
3/31/20168,79315N/A593N/A
12/31/20158,76714N/A736N/A
9/30/20159,38285N/A637N/A
6/30/20159,835175N/A775N/A
3/31/201510,145237N/A697N/A
12/31/201410,097308N/A571N/A
9/30/20149,645314N/A963N/A
6/30/20149,104311N/A461N/A
3/31/20148,895303N/A630N/A
12/31/20138,604302N/A527N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 600267 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.8%).

Earnings vs Market: 600267 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 600267 is expected to become profitable in the next 3 years.

Revenue vs Market: 600267's revenue (2.6% per year) is forecast to grow slower than the CN market (13.8% per year).

High Growth Revenue: 600267's revenue (2.6% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 600267's Return on Equity is forecast to be low in 3 years time (5%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y